Carla Morales

SF1126, a Pan-PI3K Inhibitor has Potent Pre-Clinical Activity in Aggressive B-Cell Non-Hodgkin Lymphomas by Inducing Cell Cycle Arrest and Apoptosis

W. Qi, L. Cooke, D. Mahadevan, 2012 .

Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma

R. Fisher, T. Miller, Ann M Manziello, 2012, Clinical Cancer Research.

Cancer Therapy : Preclinical Aurora A Inhibitor ( MLN 8237 ) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma

R. Fisher, T. Miller, Ann M Manziello, 2012 .